 |
|
|
| |
Safety and Pharmacokinetic Profile of Single and Multiple Ascending Doses of GS-4182, an Oral Prodrug of Lenacapavir, in Participants without HIV-1
|
| |
| |
25th International AIDS Conference (AIDS 2024); July 22–26, 2024; Munich, Germany
Naveed Shaik, Renu Singh, Ramya Rao, Sean Regan, Deqing Xiao, Furong Wang, Stephen Lau, Jason Hindman*
Gilead Sciences, Inc., Foster City, CA, USA
*Presenting author
|
| |
|
|
|
|
|
